Epilepsy in the elderly: Facts and challenges

Acta Neurologica Scandinavica

Volumn 124, Issue 4, 2011, Pages 223-237

  Stefan, H ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Comprehensive care; Differential diagnosis; Elderly; Epilepsy; Treatment

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; CARBAPENEM; CISPLATIN; CLARITHROMYCIN; DIGITOXIN; DILTIAZEM; DOMPERIDONE; DOXORUBICIN; ERYTHROMYCIN; ETIRACETAM; FELODIPINE; FLUCONAZOLE; GABAPENTIN; ISONIAZID; KETOCONAZOLE; LAMOTRIGINE; MACROLIDE; MEROPENEM; OXCARBAZEPINE; PHENOBARBITAL; PHENPROCOUMON; PHENYTOIN; THEOPHYLLINE; THIORIDAZINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; VILOXAZINE;

AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANOREXIA; ATAXIA; BRAIN DEPTH STIMULATION; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION LOSS; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DIZZINESS; DROWSINESS; DRUG TOLERABILITY; DRUG TOXICITY AND INTOXICATION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; FATIGUE; GENERAL PRACTITIONER; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPONATREMIA; ISCHEMIC HEART DISEASE; LANGUAGE DISABILITY; LOBECTOMY; LOW DRUG DOSE; MEMORY DISORDER; MORTALITY; MUSCLE HYPERTONIA; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PARESTHESIA; PERFUSION WEIGHTED IMAGING; PSYCHOGENIC NONEPILEPTIC SEIZURE; PSYCHOMOTOR DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REVIEW; SLEEP DEPRIVATION; SOMNOLENCE; STANDARDIZED MORTALITY RATIO; STEVENS JOHNSON SYNDROME; STROKE; SUSTAINED DRUG RELEASE; THYROTOXICOSIS; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION; VASCULAR DISEASE; VERTIGO; WITHDRAWAL SEIZURE;

AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; INCIDENCE; MALE; STROKE;

EID: 80053071517     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01464.x     Document Type: Review

References (134)

1. Annergers JF. Demographics and costs of epilepsy. Based on a presentation by John F. Annegers. Am J Manag Care 1998;4:453-7.
2. Riggs JE. Changing demographics and neurologic disease in the elderly. Neurol Clin 1996;14:477-86.
3. Franke H. Hoch- und Höchstbetagte: Ursachen und probleme des hohen alters. Berlin: Springer, 1987.
4. Tallis R, Hall G, Craig I, Dean A. How common are epileptic seizures in old age? Age Ageing 1991;20:442-8.
5. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures: in Rochester, Minnesota, 1935 - 1984. Epilepsia 1993;34:453-68.
6. Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes and consequences. New York: Demos Press, 1990.
7. Loiseau J, Loiseau P, Duché M et al. A survey of epileptic disorders in southwest France: seizures in elderly patients. Ann Neurol 1990;27:232-7.
8. Sander JW, Hart AS, Johnson YM, Shorvon SD. National general practice study of epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990;336:1267-71.
9. Forsgren L, Bucht G, Eriksson S et al. Incidence and clinical characterization of unprovoked seizures in adult: a prospective population based study. Epilepsia 1996;37:224-9.
10. Hauser WA. Epidemiology of seizures and epilepsy in the elderly. In: Rowan AJ, Ramseay RE, eds. Seizures and epilepsy in the elderly. Boston: Butterworth-Heinemann, 1997;7-18.
11. Sillanpää M. Incidence of epilepsy in 1986 and 2002 in Finland. Epilepsy Res 2006;71:206-15.
12. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004;62:24-9.
13. Pohlmann-Eden B, Hoch DB, Cochius JI et al. Stroke and epilepsy - critical review of the literature. Part I: epidemiology and risk factors. Cerebrovasc Dis 1996;6:332-8.
14. Thomas P, Beaeumanoir A, Genton P et al. M. "De novo" absence status of late onset: report of 11 cases. Neurology 1992;42:104-10.
15. Logroscino G, Hesdorffer DC, Cascino G et al. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia 2001;42:1031-5.
16. Hesdorffer DC, Logroscino G, Cascino G et al. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998;50:735-41.
17. Annegers JF. Cardiac deaths in epilepsy. Epilepsia 1997;38:523-5.
18. Lühdorf K, Jensen LK, Plesner M. Epilepsy in the elderly: life expectancy and causes of death. Acta Neurol Scand 1987;76:183-90.
19. Waterhouse EJ, Vaughn JK, Barnes TY. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res 1998;29:175-83.
20. Rosenow F, Hamer HM, Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia 2007;48(s8):82-4.
21. Krakow K, Pohlmann-Eden B. Epilepsie des höheren Lebensalters - eine Literaturübersicht. Epilepsie-Blätter 1997;10:54-61.
22. Pryor FM, Ramsay RE, Rowan AJ et al. Epilepsy in older adults: update from VA Cooperative Study #428. Epilepsia 2002;43:165-6.
23. Neufeld M, Kipervasser S. Usefulness of Video-EEG Monitoring in paroxysmal events in the elderly. Abstracts from the 7th European Congress on Epileptology, Helsinki, Finland, 2nd - 6th July 2006; p 119. Editor Reetta Kälviäinen.
24. Sheth RD, Drazkowski JF, Sirven JI et al. Protracted ictal confusion in elderly patients. Arch Neurol 2006;63:529-32.
25. George J. The neurological examination of the elderly patient. In: Tallis R, ed. The clinical neurology of old age. New York: Wiley and & Sons, 1989;67-75.
26. Pohlmann-Eden B, Cochius JI, Huch DB et al. Periodic lateralized epileptiform discharges - a critical review. J Clin Neurophysiol 1996;13:519-30.
27. Besser R. EEG bei Altersepilepsien. Z Epileptol 2006;1:14-6.
28. McBride AE, Shih TT, Hirsch LJ. Video-EEG monitoring in the elderly: a review of 94 patients. Epilepsia 2002;43:165-9.
29. Norris JW, Hachinski VC. Misdiagnosis of stroke. Lancet 1982;1:328-31.
30. Andermann F. Differential diagnosis of seizures in the elderly. In: Rowen AJ, Ramsey E, eds. Seizures in epilepsy in the elderly. USA: Butterworth-Heinemann, Michigan (WI), 1997:63-68.
31. Stefan H. Schlaganfall und Epilepsie auch im fortgeschrittenen Alter gut therapierbar. Extr Ger 2004;2:11-4.
32. Hakyemez B, Erdogan C, Yildiz H et al. Apparent diffusion coefficient measurements in the hippocampus and amygdala of patients with temporal lobe seizures and in healthy volunteers. Epilepsy Behav 2005;6:250-6.
33. Engelhorn T, Hufnagel A, Weise J et al. Monitoring of acute generalized status epilepticus using multimodal diffusion MR imaging: early prediction of regional neuronal damage. AJNR Am J Neuroradiol 2007;28:321-7.
34. Leone MA, Tonini MC, Bogliun G et al. Risk factors for a first epileptic seizure after stroke: a case control study. J Neurol Sci 2009;277:138-42.
35. Peinemann A, Stefan H. Altersepilepsie. Nervenarzt 1998;69:110-6.
36. Ferro JM, Pinto F. Poststroke epilepsy: epidemiology, pathophysiology and management. Drugs Aging 2004;21:639-53.
37. Camilo O, Goldstein LB. Seizures and epilepsy after ischaemic stroke. Stroke 2004;35:1769-75.
38. Myint PK, Staufenberg EF, Sabanthan K. Poststroke seizure and poststroke epilepsy. Postgrad Med. J. 2006;82:658-774.
39. Lossius MI, Ronning OM, Schlapo GD. Poststroke Epilepsie: occurrence and predictors - a longterm prospective controlled study (Akershus stroke study). Epilepsia 2005;46:1246-57.
40. Burneo JG, Fang J, Saposnik G (for the investigators of the Registry of the Canadian Stroke network). Impact of seizures on morbidity and mortality after stroke: a Canadian multicentre cohort study. Eur J Neurol 2010;17:52-8.
41. Burn J, Dennis M, Bamford J et al. Epileptic seizures after a first stroke project. Br Med J 1997;315:1582-7.
42. Benbir G, Ince B, Dozluolcay M. The epidemiology of poststroke epilepsia according to stroke subtypes. Acta Neurol Scand 2006;114:8-12.
43. Bladin CF, Alexandrov AV, Bellavance A et al. Seizures after stroke. A prospective multicenter study. Arch Neurol 2000;57:1617-22.
44. Lamy C, Domigo V, Semah F et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003;60:400-4.
45. Sung CY, Chu NS. Epileptic seizures in thrombotic stroke. J Neurol 1990;237:166-70.
46. Godfrey JW, Roberts MA, Caird FI. Epileptic seizures in the elderly: diagnostic problem. Age Ageing 1982;58:29-34.
47. Gallmetzer P, Leutmezer F, Serles W et al. Postictal paresis in focal epilepsies-Incidence, duration, and causes. A video-EEG monitoring study. Neurology 2004;62:2160-4.
48. Boesebeck F, Freermann S, Kellinghaus C et al. Misdiagnosis of epileptic and non-epileptic seizures in a neurological intensive care unit. Acta Neurol Scand 2010;122:189-95.
49. So EL, Annegers JF, Hauser WA et al. Population-based study of seizure disorders after cerebral infarction. Neurology 1996;46:350-5.
50. Heuts-van Raak EP, Boellard MA, Loder J et al. Late seizures following a first symptomatic brain infarct are related to large infarcts involving the posterior area around the lateral sulcus. Seizure 1996;5:185-94.
51. De Reuck J, Goaethals H, Claeys I et al. EEG findings after a cerebral territorial infarct in patients who develop early- and late-onset seizures. Eur Neurol 2006;55:209-13.
52. Pohlmann-Eden B, Fatar M, Hennerici M. The preserved Cortical Island sign is highly predictive of postischemic seizures. Cerebrovasc Dis 2001;12:282.
53. De Reuck J, Van Maele G. Seizures in patients with symptomatic cervical artery occlusion by dissection and by atherosclerosis. Eur J Neurol 2009;16:608-11.
54. De Reuck J, Van Maele G, Cordonnier C, Leys D. Stroke related seizures in patients with a partial anterior circulation syndrome. Acta Neurol Belg 2008;108:135-8.
55. Strong AJ, Fabricius M, Boutelle MG et al. Spreading and synchronous depression of cortical activity in acutely injured human brain. Stroke 2002;33:2738-43.
56. Tallis R. Epilepsy in elderly people. London: Martin Dunitz, 1995.
57. Cleary P, Shorwon S, Tallis R. Late-onset seizure as a predictor of subsequent stroke. Lancet 2004;363:1184-6.
58. DeReuck JN, Krahel G, Sieben L et al. Epilepsy in patients with cerebral infarcts. J Neurol 1980;224:101-9.
59. Fratiglioni L, Launer LJ, Andersen K et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the Elderly Research Group. Neurology 2000;54:10-5.
60. Hesdorffer DC, Hauser WA, Annegers JF et al. Dementis and adult-onset unprovoked seizures. Neurology 1997;48:803-6.
61. Romanelli MF, Morris LC, Ashkin K et al. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990;47:847-50.
62. Hauser WA, Morris ML, Heston LL et al. Seizures and myoclonus in patients with Alzheiner's disease. Neurology 1986;36:1226-30.
63. Mendez FM, Catanzano P, Doss RC et al. Seizures in Alzheimer′s disease: clinicopathologic study. J Geriatr Psychiatry Neurol 1994;7:230-3.
64. Gimenez-Roldan SP, Peraita JM, Lopez-Agreda JM et al. Myoclonus and photic-induced seizures in Alzheimer′s disease. Eur Neurol 1971;5:215-24.
65. Rao SC, Dove G, Cascino GD et al. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav 2009;14:118-20.
66. Sperfeld AD, Collatz MB, Baier H et al. FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol 1999;46:708-15.
67. Vercueil L. Parkinsonism and epilepsy: case report and reappraisal of an old question. Epilepsy Behav 2000;1:128-30.
68. Reinsberger C, Hopp P, Krämer G et al. Epilepsien bei demenziellen und neurodegenerativen Erkrankungen. Akt Neurol 2008;35:511-8.
69. Starr MS. The role of dopamine in epilepsy. Synapse 1996;22:159-94.
70. Chen SC. Epilepsy and migraine: the dopamine hypotheses. Med Hypotheses 2006;66:466-72.
71. Beghi E, Sander JW. The natural history and prognosis of epilepsy. In: Engel J, Pedley TA, Aicardi J, Dichter MA, Moshé S. Epilepsy: a comprehensive textbook, 2nd edn. Veröffentlicht von Lippincott: Williams & Wilkins, 2007; 65-71.
72. Cloyd JC, Leppik IE. Leppik: primidone. Absorption, distribution, and excretion. In: Levy RH, Mattson RH, Mesdrum BS, eds. Antiepileptic drugs, 4th edn. New York: Raven Press, 1995;459-66.
73. Müller WE. Besonderheiten der Psychopharmakotherapie im Alter. In: Förstel H, ed. Lehrbuch der Gerontopsychiatrie. Stuttgart: Enke, 1997;141-51.
74. Nolan LK, O′Malley O. Prescribing for the elderly. Part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988;36:142-9.
75. Cloyd J. Commonly used antiepileptic drugs: age-related pharmacokinetics. In: Rowan AJ, Ramsey RE, eds. Seizures and epilepsy in the elderly. Boston: Butterworth-Heinemann, 1997;219-28.
76. Ciorciaro C, Hartmann K, Kuhn M. Unterscheiden sich die relativen Häufigkeiten unerwünschter Arzneimittelreaktionen in Abhängigkeit vom Alter? Eine Auswertung des spontanen Meldesystems der SANZ. Schweiz Med Wochenschr 1998;128:254-8.
77. Ramsay RE, Rowan AJ, Slater JD et al. Effect of age on epilepsy and its treatment: results form the VA Co-operative study (abstract). Epilepsia 1994;35:91.
78. Cockerell OC, Johnson AL, Sander AS et al. Prognosis of epilepsy: a review and further analysis of the first nine years of the british National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997;38:31-46.
79. Mattson RH, Cramer JA, Collins JF et al. Comparison of carbamazepine, Phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-51.
80. Mattson RH, Cramer JA, Collins JF, the Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized seizures in adults. N Engl J Med 1992;327:765-71.
81. Cameron H, MacPhee GJA. Anticonvulsant therapy in the elderly - a need for placebo controlled trials. Epilepsy Res 1995;21:149-57.
82. Pederson B, Anderson G. Treatment of epilepsy in old age. In: Chadwick D, ed. Fourth International Symposium on sodium Valproate and Epilepsy. International Congress and Symposium Series Number 152: Royal Society of Medicine Services. London, 1989; 130-2.
83. Tallis R. Preventing drug reactions in the elderly: can we do better? J R Soc Med 1994;23:14-5.
84. Perucca E, Aldenkamp A, Tallis R et al. Role of valproate across the ages. Treatment of epilepsy in the elderly. Acta Neurol Scand 2006;114:28-37.
85. Giorgi L, Gomez G, O'Neill F et al. The tolerability of lamotrigine in elderly patients with epilepsy. Drugs Aging 2001;18:621-30.
86. Rowan AJ. Epilepsy in older adults. Common morbidities influence development, treatment strategies, and expected outcomes. Geriatrics 2005;60:30-2.
87. Glauser T, Ben-Menachem E, Bourgeois B et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-120.
88. Rowan AJ, Ramsay RE, Collins JF et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-73.
89. Rowan AJ, Ramsay RE, Collins JF et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine in patients with poststroke seizure. Clin Neuropharmacol 2007;30:189-95.
90. Saetre E, Perucca E, Isojarvi J, Gjerstad L. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007;48:1292-302.
91. Karceski S, Morell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion. Epilepsy Behav 2005;7:1-64.
92. Krämer G, May T, Schmitz B et al. Epilepsiebehandlung bei Erwachsenen 2007: Ergebnisse einer Expertenbefragung in Deutschland, Österreich und der Schweiz. Akt Neurol 2007;34:121.
93. Mattson R, Kamin M. Seizure freedom with topiramate: results from an open follow on to a double blind titration study. Epilepsia 1998;39:55.
94. Stefan H, Hubbertz L, Peglan J et al. Epilepsy outcomes in elderly treated with topiramate. Acta Neurol Scand 2008;118:169-74.
95. Ramsay RE, Uthman B, Pryor FM et al. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study. Epilepsia 2008;49:1180-5.
96. Morrell MJ, Leppik I, Frechn J et al. The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study. Epilepsy Res 2003;54:153-61.
97. Werhahn KJ. Epileptische Anfälle im Alter. Nervenarzt 2009; 80: 399-404.
98. Dogan EA, Usta BE, Bilgen R et al. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. Epilepsy Behav 2008;13:156-61.
99. Elger C, Bialer M, Cramer JA et al. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 2007;48:497-504.
100. Azar NJ, Abou-Khalil BW. Considerations in the choice of an antiepileptic drug in the treatment of epilepsy. Semin Neurol 2008;28:305-16.
101. Pugh MJ, Van Cott AC, Cramer JA et al. Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004. Neurology 2008;70:2171-8.
102. Papazian O, Canizales E, Alfonso I, Archilla R. Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 1995;38:687-91.
103. Cordonnier C, Henon H, Derambure P et al. Early epileptic seizures after stroke are associated with increased risk of new-onset dementia. J Neurol Neurosurg Psychiatry 2007;78:514-6.
104. Kwan J, Guenther A. Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Database Syst Rev 2006;3:CD005501.
105. Adams HP Jr, Del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711.
106. Ryvlin P, Montavont A, Nighoghossian N. Optimizing therapy of seizures in stroke patients. Neurology 2006;67:3-9.
107. Myint PK, Staufenberg EF, Sabanathan K. Post-stroke seizure and post-stroke epilepsy. Postgrad Med J 2006;82: 568-72.
108. Ringleb P, Schellinger PD, Hacke W. Leitlinien zum Management von Patienten mit akutem Hirninfarkt oder TIA der Europäischen Schlaganfallorganisation 2008. Nervenarzt 2008;79:936-57.
109. Grivas A, Schramm J, Kral T et al. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia 2006;47:1364-72.
110. Acosta I, Vale F, Atum WO IV et al. Epilepsy surgery after age 60. Epilepsy Behav 2008;12:324.
111. Bachmann K. Coronal heart disease. In: Blatt D, ed. Altersmedizin. Stuttgart, New York: Schattauer-Verlag, 1997;59-71.
112. Hüll M, Bauer J. Alzheimer disease and vascular dementia. In: Blatt D, ed. Altersmedizin. Stuttgart, New York: Schattauer-Verlag, 1997;520-54.
113. Schmidt D, Seldon L. Adverse effects of antiepileptic drugs. New York: Raven Press, 1982.
114. Bartl R. Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment. Dtsch Med Wochenschr 2007;132:1475-9.
115. Rowe DJ. Disturbance of calcium metabolism by anticonvulsant drugs. Br med. J 1970;4:73-6.
116. Pack AM, Olarte LS, Morrell MJ et al. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 2003;4:169-74.
117. Pack AM, Morrell MJ, Marcus R et al. Bone mass and turnover in women with epilepsy on antiepileptic drugs monotherapy. Ann Neurol 2005;57:252-7.
118. Briggs DE, French JA. Levetiracetam safety profiles and tolerability in epilepsy patients. Expert Opin Drug Saf 2004;3:415-24.
119. Sheth RD. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995;127:256-62.
120. Nissen-Meyer LS, Svalheim S, Taubøll E et al. How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal students. Seizure 2008;17:187-91.
121. Pack AM. The association between antiepileptic drugs and bone disease. Epilepsy Curr 2003;3:91-5.
122. Vestergaard P. Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy. Curr Drug Saf 2008;4:168-72.
123. Nissen-Meyers LS, Svalheim S, Taubøll E et al. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure and metabolism. Epilepsia 2007;48:1850-60.
124. Coppola G, Fortunato D, Auricchio G et al. Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia 2009;50:2140-6.
125. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004;45:1330-7.
126. Sheth RD, Hermann BP. Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol 2007;37:250-4.
127. Ensrud KE, Walczak TS, Blackwell TL et al. Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology 2008;71:723-30.
128. Garrard J, Cloyd J, Gross C et al. Factors associated with antiepileptic drug use among elderly nursing home residents. J Gerontol A Biol Sci Med Sci 2000;55:384-92.
129. Hanlon JT, Schmader KE, Koronkowski MJ et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1998;46:252-3.
130. Cooper JW. Probable adverse drug reaction in a rural geriatric nursing home population: a four-years study. JAGS 1996;44:194-7.
131. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16.
132. Haupt M. Depressive Störungen im Alter - Kofaktoren, Kosyndrome und Komorbidität. NeuroGeriatrie 2004;1:25-31.
133. Fife TD, Blum D, Fisher RS. Measuring the effect of antiepileptic medications on balance in older people. Epilepsy Res 2006;70:103-9.
134. Flierl-Hecht A, Pfäfflin M, May TW et al. Werden Epilepsien bei älteren Menschen übersehen? Eine Untersuchung in Altersheimen. Nervenarzt 2003;74:691-8.